Bio-Rad Laboratories Reaches New 12-Month High at $133.33 (BIO)
Bio-Rad Laboratories (NYSE:BIO)’s share price reached a new 52-week high during trading on Tuesday , AnalystRatingsNetwork reports. The stock traded as high as $133.33 and last traded at $132.07, with a volume of 69,138 shares. The stock had previously closed at $131.59.
A number of research firms have recently commented on BIO. Analysts at Zacks upgraded shares of Bio-Rad Laboratories from an “underperform” rating to a “neutral” rating in a research note on Wednesday, January 15th. They now have a $131.00 price target on the stock.
The stock’s 50-day moving average is $127.1 and its 200-day moving average is $121.6. The company has a market cap of $3.788 billion and a P/E ratio of 42.49.
Bio-Rad Laboratories, Inc (NYSE:BIO) manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.